Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-26 @ 12:01 AM
NCT ID:
NCT02619994
Group ID:
EG001
Title:
Experimental Arm
Description:
Regimen consists of only oral medication using delamanid, linezolid, levofloxacin, and pyrazinamide, for nine or twelve months depending on the time of sputum culture conversion to negative.
* Delamanid (100 mg bid for the entire treatment period)
* Linezolid (600mg/day for 2 months and 300mg/day afterwards until the end of treatment)
* Levofloxacin (750 \~1000 mg/day)
* Pyrazinamide (1000\~ 2000 mg/day)
Linezolid
Delamanid
Levofloxacin
Pyrazinamide
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
20
Serious Number At Risk:
79
Other Number Affected:
78
Other Number At Risk:
79
Study:
NCT02619994
Results Section:
NCT02619994
Adverse Events Module:
NCT02619994